New Key Statistics Module, Z-Score and F-Score
NYSE:BMY Key Ratios
Market Cap $ M | 99,027.43 |
Enterprise Value $ M | 128,474.91 |
P/E(ttm) | 12.66 |
PE Ratio without NRI | 6.51 |
Forward PE Ratio | 7.03 |
Price/Book | 3.36 |
Price/Sales | 2.25 |
Price/Free Cash Flow | 8.01 |
Price/Owner Earnings | 8.46 |
Payout Ratio % | 0.31 |
Revenue (TTM) $ M | 45,006.00 |
EPS (TTM) $ | 3.86 |
Beneish M-Score | -2.79 |
10-y EBITDA Growth Rate % | 17.30 |
5-y EBITDA Growth Rate % | 24.50 |
y-y EBITDA Growth Rate % | 4.10 |
EV-to-EBIT | 13.37 |
EV-to-EBITDA | 6.63 |
PEG | 0.27 |
Shares Outstanding M | 2,026.76 |
Net Margin (%) | 17.83 |
Operating Margin % | 18.21 |
Pre-tax Margin (%) | 18.75 |
Quick Ratio | 1.31 |
Current Ratio | 1.43 |
ROA % (ttm) | 8.52 |
ROE % (ttm) | 26.18 |
ROIC % (ttm) | 9.60 |
Dividend Yield % | 4.75 |
Altman Z-Score | 2.26 |
BMY Number of Guru Trades
BMY Volume of Guru Trades
Gurus Latest Trades with NYSE:BMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:BMY is held by these investors
Total 11
Bristol-Myers Squibb Co Insider Transactions
No Available Data
News about NYSE:BMY
Total 0- 1